8-KFiled Aug 5, 8:00 PM ET

Outset Medical Reports Q2 2026 Results

$OM · Outset Medical, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Outset Medical Reports Q2 2026 Results

What Happened

  • On August 6, 2026, Outset Medical, Inc. announced it issued a press release and will hold a conference call to report its financial results for the quarter ended June 30, 2026. The company furnished the press release as Exhibit 99.1 to Form 8‑K. The filing is made under Item 2.02 (Results of Operations and Financial Condition) and was signed by CFO Renee Gaeta.

Key Details

  • Press release titled “Outset Medical Reports Second Quarter 2026 Results” furnished as Exhibit 99.1 (dated August 6, 2026).
  • Reporting period: quarter ended June 30, 2026 (Q2 2026).
  • Item of the 8‑K: 2.02 (Results of Operations and Financial Condition); Exhibit disclosure under 9.01.
  • Form 8‑K signed by Chief Financial Officer Renee Gaeta on August 6, 2026.

Why It Matters

  • This filing signals that the company is publicly releasing its quarterly earnings and related metrics (earnings, revenue, cash flow) and will host a conference call—events that can move the stock and inform investor decisions.
  • Retail investors should review the press release (Exhibit 99.1) and listen to the earnings call for the actual financial figures, management commentary, and any updated guidance.